In HNSCC, CERCAM promotes malignant biological behavior of tumor and M2 polarized immune infiltration of macrophages, which are independent risk factors for predicting OS in patients [19].However, CERCAM has not been shown to be an independent prognostic risk factor in breast cancer. Here, CERCAM is linked to head and neck squamous cell carcinoma.